☆
4.7
Meeting Abstract
Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+B-Lineage Standard and High Risk Patients; Results of 263 CD20+Patients Studied Prospectively In GMALL Study 07/2003
BLOOD (2010)
评价这篇论文
主要评分表示论文的整体质量水平。次要评分独立反映论文的优点或缺点。
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now